Determination of the Prognostic Utility of Immunohistochemically Assessed hENT1 Expression in Resected Hilar Cholangiocarcinoma Patients. (2021) - Bird, N.; Manu, N.; Quinn, M.; Gill, T.; Fenwick, S.; Diaz-Nieto, R.; Jones, R.; Malik, H.